I'm not sure I understand your distinction. While the district court may have agreed with that Novartis's withholding of certain information to protect its trade secrets was not correct, the Federal Circuit in Washington appears now to have blessed that approach (no doubt well mapped in advance by Novertis's in house lawyers) as being the correct one.
News 
Market Data 
Discover 
AI
